This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Robert J. Levine, MD
Yale University School of Medicine New Haven, Conn

JAMA. 1975;231(9):914-915.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The article, "Diagnosis and Treatment of Malignant Carcinoid Syndrome," by Dr. A. L. Ureles (229:1346, 1974) contains several serious errors. In this letter I shall concentrate on those that have substantial patient-care implications. Documentation of the statements I shall make may be found in a recent textbook chapter¹ that will also provide access to the primary literature from which they are derived. I shall restrain myself from taking issue with the several incorrect statements that are likely to be more of interest to professional pedants than to practicing physicians who wish to understand how to safely and effectively diagnose and treat the carcinoid syndrome.

The dose of epinephrine that Dr. Ureles designates for intravenous administration to perform the epinephrine provocative test is 5 mg. He concludes: "Reports of severe vascular collapse and paradoxical hypertension would suggest, however, that pressor amines should be avoided in the evaluation . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?